Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic (Q30404293)

21 June 2017

1 reference

title

Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic (English)

1 reference

21 June 2017

0 references

pandemic preparedness

1 reference

1 reference

Anandi N Sheth

1

1 reference

21 June 2017

Pragna Patel

series ordinal

2

1 reference

21 June 2017

Philip J Peters

series ordinal

3

1 reference

21 June 2017

1 September 2011

1 reference

21 June 2017

Current HIV/AIDS reports

1 reference

21 June 2017

8

1 reference

21 June 2017

3

1 reference

21 June 2017

181-191

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0086-4

21 June 2017

0 references

cites work

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Australia's winter with the 2009 pandemic influenza A (H1N1) virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Influenza A H1N1 in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Cigarette smoking and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Pandemic (H1N1) 2009 influenza in HIV-infected adults: clinical features, severity, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Pandemic influenza A (H1N1) in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1)--United States, spring and summer 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Clinical signs and symptoms predicting influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

The laboratory evaluation of opportunistic pulmonary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Rapid diagnostic tests for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Rapid influenza antigen test for diagnosis of pandemic (H1N1) 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Fatal case of pneumonia associated with pandemic (H1N1) 2009 in HIV-positive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Pandemic (H1N1) 2009 and HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Influenza-associated morbidity and mortality in young and middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Fatalities associated with the 2009 H1N1 influenza A virus in New York city

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Activation of virus replication after vaccination of HIV-1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Pandemic influenza vaccine in adult HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0086-4

Influenza vaccination of HIV-1-positive and hiv-1-negative former intravenous drug users

21 January 2018

1 reference

12 December 2020

Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients

1 reference

12 December 2020

Pandemic H1N1 influenza in Brazil: analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI)

1 reference

12 December 2020

Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006.

1 reference

12 December 2020

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

It's not all swine flu...are we missing opportunities to diagnose primary HIV infection in patients with flu symptoms?

1 reference

12 December 2020

Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop

1 reference

12 December 2020

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza

1 reference

12 December 2020

Update: influenza activity - United States, 2009-10 season

1 reference

12 December 2020

Immunogenicity of influenza vaccine in patients with hemato-oncological disorders

1 reference

12 December 2020

Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy

1 reference

12 December 2020

Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza

1 reference

12 December 2020

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

1 reference

12 December 2020

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings

1 reference

12 December 2020

Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009.

1 reference

12 December 2020

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

1 reference

12 December 2020

10.1007/S11904-011-0086-4

Identifiers

DOI

1 reference

Dimensions Publication ID

21 June 2017

1053292571

0 references

Fatcat ID

release_okbsbuo3x5astdfisfixyx5t5y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/okbsbuo3x5astdfisfixyx5t5y

24 November 2022

mapped directly with Wikidata item

1 reference